WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,791 Cr | ₹3,435 Cr | ₹3,207 Cr | ₹3,121 Cr | ₹3,497 Cr |
What is the latest Total Current Liabilities ratio of WOCKHARDT ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,791 Cr |
Mar2023 | ₹3,435 Cr |
Mar2022 | ₹3,207 Cr |
Mar2021 | ₹3,121 Cr |
Mar2020 | ₹3,497 Cr |
How is Total Current Liabilities of WOCKHARDT Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,791 Cr | -18.75 | |
Mar2023 | ₹3,435 Cr | 7.11 | |
Mar2022 | ₹3,207 Cr | 2.76 | |
Mar2021 | ₹3,121 Cr | -10.76 | |
Mar2020 | ₹3,497 Cr | - |
Compare Total Current Liabilities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹22,838.6 Cr | 6.6% | -2.8% | 198.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 6.6% |
-2.8% |
198.4% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses